“…the R.A.D.A.R. solution features built-in biometric technology to verify the identities of subjects undergoing testing. “
Colorado-based Lifeloc Technologies is banking on new product offerings to make it the world’s leading provider of real-time alcohol and drug abuse detection, with biometric technology playing an important role.
In the company’s latest quarterly update, it indicated that the flagship breathalyzer model of its new platform, the Lifeloc LX9, has gone into production, while the latest model of its Real-time Alcohol Detection and Reporting, or R.A.D.A.R., device – billed as an alternative to incarceration for offenders – has gone into prototype testing. Importantly, the R.A.D.A.R. solution features built-in biometric technology to verify the identities of subjects undergoing testing.
“R.A.D.A.R. devices are a critical step in moving our business towards a recurring revenue model,” the company stated.
It’s another indication of the growing role for biometrics in drug and alcohol testing, with automated breathalyzer kiosks featuring biometric authentication making their way into county jails and being pitched to parole and probation officials.
For its part, Lifeloc appears to be on steady footing, reporting a net income of $31 thousand for its latest fiscal quarter, compared to a net income of $11 thousand a year ago. “We have been investing aggressively in product development to achieve this vision, focusing on a few major product developments that are expected to have a significant impact on our performance,” the company stated in its update. “We are now at the point where we will start to reap the benefit of these investments.”
June 7, 2019 – by Alex Perala